683 Capital Management’s MacroGenics MGNX Stock Holding History

683 Capital Management’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-400,000	Closed	-$5.1M	–	175
2019 Q3	$5.1M	Sell	400,000 -134,970	-25%	-$1.94M	0.57%	45
2019 Q2	$9.08M	Buy	534,970 +50,000	+10%	+$859K	0.83%	33
2019 Q1	$8.72M	Buy	484,970 +100,000	+26%	+$1.73M	0.79%	33
2018 Q4	$4.89M	Buy	384,970 +49,336	+15%	+$827K	0.3%	59
2018 Q3	$7.2M	Buy	335,634 +73,034	+28%	+$1.56M	0.47%	48
2018 Q2	$5.42M	Buy	262,600 +12,600	+5%	+$284K	0.37%	52
2018 Q1	$6.29M	Buy	+250,000	New	+$6.07M	0.56%	49

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

683 Capital Management's MGNX Position: Q4 2019 in Review

683 Capital Management sold out of MacroGenics (MGNX) in Q4 2019, closing a stake of 400,000 shares — an estimated $5.1M sold.

683 Capital Management first reported a position in MGNX in Q1 2018 and held it in 7 quarters. The position peaked at $9.08M in Q2 2019. 124 funds tracked by Wall St. Rank hold MGNX as of Q4 2019.

683 Capital Management reported no remaining MacroGenics position as of Q4 2019 after selling out during the quarter.
683 Capital Management sold 400,000 MacroGenics shares in Q4 2019, an estimated $5.1M.
683 Capital Management first reported a position in MacroGenics in Q1 2018 and held it in 7 quarters.
683 Capital Management's MacroGenics position peaked at $9.08M in Q2 2019.
124 funds tracked by Wall St. Rank held MacroGenics as of Q4 2019.

Based on 683 Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.